Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how much money has been spent on the prescription of drugs to manage epilepsy in the NHS in each of the last five years.
Information on the cost of medicines to treat epilepsy is shown in the table.
Net Ingredient Cost of medicines dispensed in England to treat epilepsy, as defined by British National Formulary (BNF) Section 4.8.1 Control of the epilepsies and 4.8.2 Drugs used in status epilepticus. | ||
| Primary care cost (£) | Secondary care cost (£) |
2014/15 Q1 only | 117,954,639 | 8,972,447 |
2013/14 | 455,561,100 | 33,557,584 |
2012/13 | 397,626,888 | 29,691,830 |
2011/12 | 382,640,431 | 27,282,775 |
2010/11 | 346,221,736 | 25,390,620 |
2009/10 | 304,583,390 | 23,954,258 |
Source:
Prescription Cost Analysis (PCA) provided by the Health and Social Care Information Centre (primary care)
Hospital Pharmacy Audit Index (HPAI) provided by IMS Health (secondary care)
Notes:
Net Ingredient Cost (NIC)
NIC is the basic cost of a drug. It does not take account of discounts, dispensing costs, fees or prescription charges income.
BNF Classifications
The PCA system uses the therapeutic classifications defined in the BNF. Information on why a drug is prescribed is not available in this dataset. Since drugs can be prescribed to treat more than one condition, it may not be possible to separate the different conditions for which a drug may have been prescribed.